Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
Alphatec Holdings
ATEC
$1.69B
| $93K | ﹤0.01% |
49,590
-1,024
| -2% | -$2.07K |
2013 Q2
16 quarters
|
|
3802
Centrus Energy
LEU
$2.6B
| $93K | ﹤0.01% |
22,164
| – | – |
2015 Q1
9 quarters
|
|
|
LOV
3803
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $93K | ﹤0.01% |
97,541
| – | – |
2013 Q2
16 quarters
|
|
3804
Allot
ALLT
$446M
| $92K | ﹤0.01% |
18,186
-4,860
| -21% | -$23.8K |
2015 Q1
9 quarters
|
|
|
BIOC
3805
DELISTED
Biocept, Inc.
BIOC
| $92K | ﹤0.01% |
7
+4
| +133% | +$56.5K |
2015 Q1
9 quarters
|
|
|
FOMX
3806
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $92K | ﹤0.01% |
19,970
-123
| -0.6% | -$549 |
2015 Q2
8 quarters
|
|
|
ELON
3807
DELISTED
Echelon Corp
ELON
| $91K | ﹤0.01% |
17,536
+2,600
| +17% | +$16K |
2013 Q2
16 quarters
|
|
|
UNXL
3808
DELISTED
Uni-Pixel, Inc.
UNXL
| $90K | ﹤0.01% |
236,495
-3,806
| -2% | -$2.02K |
2013 Q2
16 quarters
|
|
3809
DELISTED
Carisma Therapeutics
CARM
| $88K | ﹤0.01% |
2,811
+452
| +19% | +$15.1K |
2014 Q1
13 quarters
|
|
3810
DELISTED
ENGlobal Corp
ENG
| $88K | ﹤0.01% |
8,462
| – | – |
2013 Q2
16 quarters
|
|
|
ENZY
3811
DELISTED
Enzymotec Ltd
ENZY
| $88K | ﹤0.01% |
10,987
-3,396
| -24% | -$28.3K |
2016 Q1
5 quarters
|
|
3812
Sonoma Pharmaceuticals
SNOA
$5.51M
| $87K | ﹤0.01% |
73
-10
| -12% | -$12.3K |
2014 Q1
13 quarters
|
|
3813
DELISTED
Streamline Health Solutions
STRM
| $85K | ﹤0.01% |
5,315
| – | – |
2013 Q2
16 quarters
|
|
3814
Savara
SVRA
$974M
| $85K | ﹤0.01% |
14,464
-1
| -0% | -$7 |
2013 Q2
16 quarters
|
|
|
IGR
3815
CBRE Global Real Estate Income Fund
IGR
$567M
| $84K | ﹤0.01% |
+3,668
| New | +$83.9K |
2017 Q2
0 quarters
|
|
3816
CEL-SCI Corp
CVM
$30.6M
| $83K | ﹤0.01% |
1,255
+694
| +124% | +$48.3K |
2013 Q2
16 quarters
|
|
3817
InfuSystem Holdings
INFU
$277M
| $83K | ﹤0.01% |
46,642
| – | – |
2014 Q3
11 quarters
|
|
3818
RAVE Restaurant Group
RAVE
$31.4M
| $83K | ﹤0.01% |
41,524
| – | – |
2015 Q2
8 quarters
|
|
3819
Sypris Solutions
SYPR
$41.2M
| $83K | ﹤0.01% |
50,846
-4,300
| -8% | -$5.79K |
2013 Q2
16 quarters
|
|
3820
ADMA Biologics
ADMA
$2.4B
| $82K | ﹤0.01% |
21,526
-2,032
| -9% | -$8.16K |
2016 Q3
3 quarters
|
|
3821
Bio Green Med Solution Inc
BGMS
$5.51M
| – | – |
0
| – | – |
2017 Q2
0 quarters
|
|
|
TST
3822
DELISTED
TheStreet, Inc.
TST
| $81K | ﹤0.01% |
9,786
-784
| -7% | -$6.64K |
2013 Q2
16 quarters
|
|
3823
Aemetis
AMTX
$105M
| $80K | ﹤0.01% |
59,740
-4,455
| -7% | -$5.93K |
2014 Q3
11 quarters
|
|
|
DTEA
3824
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $80K | ﹤0.01% |
13,680
-3,186
| -19% | -$20.4K |
2015 Q4
6 quarters
|
|
|
QTRH
3825
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $80K | ﹤0.01% |
+55,676
| New | +$80.4K |
2017 Q2
0 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.